Reframing pharmaceutical production around process stability, real-time quality assurance, and regulatory alignment in the ...

At the just completed BioProcess International Conference in Boston, a number of sessions focused on the Bioprocess 4.0 trend toward continuous bioprocessing operations. Akshat Mullerpatan, PhD, ...

Continuous processing, already conventional in many manufacturing fields, has been establishing itself in biopharma, which is starting to realize continuous processing’s compelling advantages: ...

Moving away from fed-batch has significant sustainability and cost-saving benefits, according to industry working groups.

Having assessed the responses to our survey of technology suppliers about expected automation purchasing and use trends in the discrete and batch manufacturing industries, we now turn our attention to ...

Traditionally, vaccine manufacture has accounted for a huge amount of aseptic production. In recent years, there has been a larger focus on novel biologic therapies, of which the majority are ...